AIMD - Ainos, Inc.

1.38
-0.090   -6.522%

Share volume: 24,374
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations: 3.26%

PREVIOUS CLOSE
CHG
CHG%
$1.47
-0.09
-0.06%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
41%
Profitability 35%
Dept financing 31%
Liquidity 75%
Performance 40%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-12.66%
1 Month
-26.60%
3 Months
-37.27%
6 Months
-61.77%
1 Year
182.21%
2 Year
23.21%
Key data
Stock price
$1.38
P/E Ratio 
0.00
DAY RANGE
$1.36 - $1.44
EPS 
-$2.33
52 WEEK RANGE
$0.42 - $4.50
52 WEEK CHANGE
$199.87
MARKET CAP 
16.139 M
YIELD 
N/A
SHARES OUTSTANDING 
4.813 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-12-2025
BETA 
2.08
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$34,992
AVERAGE 30 VOLUME 
$62,977
Company detail
CEO: Chun-Hsien Tsai
Region: US
Website: ainos.com
Employees: 40
IPO year: 2007
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

Ainos, Inc. engages in the developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App.

Recent news